Speakers

  • Paul Turner, PhD
    Henry Ford II Professor and Departmental Chair of Ecology and Evolutionary Biology, Microbiology Faculty, Yale School of Medicine
    Biography
      Paul Turner is the Elihu Professor of Ecology and Evolutionary Biology at Yale University, where he has served as Interim Dean of Science and Departmental Chair. He is also a faculty member in Microbiology at Yale University School of Medicine. Dr. Turner's research interests include: evolutionary biology, evolutionary medicine, infectious disease, microbiology, phage therapy, RNA viruses, vector-borne disease, and virology. He uses an interdisciplinary approach in his research laboratory, employing techniques from microbiology, population genetics, genomics, molecular biology and mathematical modeling to study hypotheses in ecology and evolutionary biology. Paul Turner received his Ph.D. from the Center for Microbial Ecology at Michigan State University. He then conducted postdoctoral work at University of Maryland College Park, University of Valencia in Spain, and the National Institutes of Health. He regularly serves on committees for the National Science Foundation, National Institutes of Health and the American Society for Microbiology. He was elected chair of international meetings, such as the 2013 Gordon Research Conference on Microbial Population Biology, and the 2018 Jacques Monod Conference on Viral Emergence. He has authored nearly 100 scholarly journal articles, reviews and book chapters.
    • Neil Osheroff, PhD
      Professor of Biochemistry, John Coniglio Chair in Biochemistry, Vanderbilt University School of Medicine
      Biography
        Neil Osheroff received a Bachelor's Degree in Chemistry from Hobart College in 1974 followed by a Ph.D. in Biochemistry and Molecular Biology from Northwestern University in 1979. His doctoral dissertation on the mechanism of action of cytochrome c was under the direction of Professor Emanuel Margoliash. Following his doctoral studies, Dr. Osheroff moved to the Stanford University School of Medicine in 1980, where he was a Helen Hay Whitney Foundation postdoctoral fellow with Dr. Douglas Brutlag in the Department of Biochemistry. In 1983, he moved to the Vanderbilt University School of Medicine as an Assistant Professor of Biochemistry and he has been on the faculty since that time. Dr. Osheroff currently holds Professorships in the Departments of Biochemistry and Medicine and was endowed with the John G. Coniglio Chair in Biochemistry in 2003. He has spent a combined 27 years on the editorial boards of The Journal of Biological Chemistry and Biochemistry and has authored over 240 publications. Dr. Osheroff's research focuses on topoisomerases, enzymes that remove knots and tangles from the genetic material and modulate torsional stress in DNA. In addition to their critical physiological roles, human type I and II topoisomerases are the targets for a number of widely used anticancer drugs. Furthermore, bacterial type II topoisomerases are the targets for quinolones, a drug class that includes some of the most frequently prescribed antibacterials in the world. The Osheroff laboratory has made seminal contributions to our understanding of how topoisomerases function and how anticancer drugs, natural products, and antibacterials interact with these enzymes and alter their catalytic functions. Beyond his research, Dr. Osheroff has a long-standing interest in mentoring and training young scientists and physicians. Twenty-seven Ph.D. students have graduated under his mentorship. Dr. Osheroff he has been a course director since 1990 and holds a number of educational leadership positions in the Vanderbilt University School of Medicine. Dr. Osheroff Chaired the NCI-I "Transition to Independence" study section from 2013-2016 and has held leadership positions in two international medical science educator organizations. Finally, Dr. Osheroff has received awards for mentoring, teaching, curricular design, educational service, and affirmative action and diversity. Over the past five years, he has been invited to present more than seventy scientific and educational talks at forty-six institutions/meetings in seventeen different countries.
      • Condie Carmack, PhD
        Vice President of Precision Oncology, Vela Dx
        Biography
          Condie Carmack, Ph.D. received his Ph.D. from the University of Utah in Experimental Pathology and did postdocs in Philadelphia, PA and San Diego, CA. in mouse genetics and molecular biology. He is the author or or co-author of 23 peer-reviewed journal. He wrote the first paper on quantitative PCR and the second paper on multiplex PCR. He served on the Science Advisory Board of Life Technologies Inc. as an expert in clinical PCR. He was co-author on the first paper creating human monoclonal antibodies from immunodeficient mice. Mice serve as the foundation for creation of the current immune checkpoint blockade antibodies such as ipilimumab and nivolumab. He also served as General Manager of the Cancer Genetics Lab at Baylor College of Medicine before joining Vela Diagnostics
        • Charles Chiu, MD, PhD
          Associate Professor, Laboratory Medicine and Medicine / Infectious Diseases Director, UCSF-Abbott Viral Diagnostics and Discovery Center Associate Director, UCSF Clinical Microbiology Laborat
          Biography
            Dr. Charles Chiu, M.D./Ph.D., is an Assistant Professor in Laboratory Medicine and Medicine, Infectious Diseases at the University of California, San Francisco. He is also the Director of UCSF-Abbott Viral Diagnostics and Discovery Center (VDDC) at China Basin and Associate Director of the UCSF Clinical Microbiology Laboratory. Charles is an expert in the emerging field of viral metagenomics, and his research is focused on the development of microarray and deep sequencing technologies for viral pathogen discovery and clinical diagnostics. He is also the principal investigator on an R01 grant from the NIH on blood bank pathogen screening, California Discovery, UC-MEXUS, and National Research Fund for Tickborne Diseases (NRFTD) grants on the microbial epidemiology of encephalitis, diarrhea, and Lyme disease, a QB3 Rogers Family Foundation Award in translational diagnostics, and a UCSF-Abbott Viral Discovery Award. Charles has more than 30 patents and peer-reviewed publications in scientific journals and ongoing collaborations with research groups and public health agencies worldwide, including Abbott Diagnostics, Inc., Global Viral Forecasting, the United States CDC, the American Red Cross, and the Texas Biomedical Research Institute.
          • Nathan Crook, PhD
            Postdoctoral Research Scholar , Washington University School of Medicine
            Biography
              Nathan Crook is a postdoctoral researcher in the Department of Pathology & Immunology at Washington University School of Medicine in the laboratory of Prof. Gautam Dantas, where he is applying functional metagenomics and next-generation sequencing to improve control over colonization and gene expression in probiotic bacteria. Nathan received his B.S. in Chemical Engineering from the California Institute of Technology in 2009, and his PhD in Chemical Engineering from the University of Texas at Austin in 2014. During his graduate work in the Alper Lab, Nathan developed several high-throughput computational and experimental methods which accelerate the engineering of new industrial phenotypes in S. cerevisiae. In the future, Nathan aims to engineer probiotics for in situ synthesis and delivery of therapeutics. Nathan has published 10 papers relating to his work, in addition to 2 book chapters and 3 review articles. He has mentored 2 high school students, 6 undergraduates, and 4 graduate students in experimental synthetic biology research. Nathan received the National Science Foundation's Graduate Research Fellowship in 2010.
            • Rob Dunn, PhD
              Professor, Applied Ecology, NC State University
              Biography
                Rob Dunn is an ecologist in the Department of Applied Ecology at North Carolina State University. His research focuses on the ecology and evolution of the daily life of societies, be they those of humans or ants. This includes work on face mites, belly button bacteria, beetles that ride on ants as they move from place to place and house cats. He has published more than a hundred scientific articles (www.robdunnlab.com). Among those articles, he is really fond of some that no one ever reads and would like to rewrite others that get read fairly often. His work often engages the public, either directly in participatory science (www.yourwildlife.org), or through telling stories about the process of science. It is in telling those stories that Rob writes for Natural History, National Geographic, Scientific American, New Scientist and BBC Wildlife magazines. He has coordinated a series of books on the most common species of ants in North America, New York City, California, and Chicago. He has written five books for general audiences, Every Living Thing, The Wild Life of Our Bodies and, most recently, The Man Who Touched His Own Heart, which tells the stories of the, often fumbling, human attempts to understand and mend the human heart over the course of the last eight thousand years, Never Out of Season and, to be released in 2018, Never Home Alone.
              • Megan Hochstrasser, PhD
                Science Communications Manager, Innovative Genomics Institute
                Biography
                  Megan has a B.A. in Biology from Brown University and received her Ph.D. from Jennifer Doudna's lab at UC Berkeley in 2016, where she studied mechanisms of CRISPR immunity in bacteria. She joined the IGI in September 2016 to handle scientific communications, hoping to bridge the gap between researchers and the public.
                • Levi Kirwin
                  Director, Commercial Marketing, Accelerate Diagnostics
                  Biography
                    Levi Kirwin is the director of commercial marketing at Accelerate Diagnostics, with fifteen years' experience as a chemist, microbiologist, and life sciences/medical device marketing professionl. He has a BS Microbiology from Texas Tech University and MBA from the University of Tampa, and is committed to partnering with laboratory and clinical professionals alike to provide new diagnostic tools that save lives for patients with bloodstream infections.
                  • Sabra Klein, PhD
                    Associate Professor, Molecular Microbiology and Immunology, Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health
                    Biography
                      Sabra L. Klein, Ph.D. received her B.A. in Psychology from Randolph-Macon College, her M.S. from the University of Georgia in Biological Psychology, and her Ph.D. in Behavioral Neuroscience from Johns Hopkins University. She did postdoctoral training at the Johns Hopkins Bloomberg School of Public Health in Molecular Microbiology and Immunology where she is now an Associate Professor. Dr. Klein is a leading expert on sex differences in immune responses and susceptibility to infection and currently has over 100 peer-reviewed publications, authored several book chapters, and edited two books on the broad topics of sex differences in response to infection and treatments for infectious diseases. During the 2009 influenza pandemic, she was commissioned by the WHO to evaluate and publish a report on the impact of sex, gender, and pregnancy on the outcome of influenza virus infection. Dr. Klein also has been invited to write reviews to introduce journal policies about sex reporting, wrote an Op Ed in the New York Times about sex-specific dosing of vaccines, and was lead author on an Opinion piece in PNAS defining the importance of sex as a biological variable in biomedical science. Her research has been highlighted in commentaries appearing in PNAS, Nature, and U.S. News and World Reports. Her research has been supported by grants from the National Institute of Allergy and Infectious Diseases, the National Science Foundation, and the National Foundation for Infectious Diseases. In 2010, she won the Society for Women's Health Research Medtronic Award for Science Contributions, which recognized her scientific contributions as well as her commitment to mentoring other female scientists.
                    • Punya Nachappa, PhD
                      Associate Professor, Department of Biology, Purdue University
                      Biography
                        Dr. Punya Nachappa Ph.D., is an Associate Professor in the Department of Biology at Purdue University, Fort Wayne. With a background in agriculture, specializing in entomology, Dr. Nachappa studies insects that transmit microbes or pathogens that causes diseases in plants such as soybeans. During her first year at Purdue, a new soybean virus was discovered which has become a big focus of her research. When trying to study the interaction between the virus, its insect vector and the host plant Dr. Nachappa and her students found that insects carrying the virus have better reproduction rates than insects who do not. Understanding the interaction between the insect and virus, and what it means to growers, is the focus for the future. Dr. Nachappa has more than 15 peer-reviewed publications in scientific journals and over a million dollar in funding from federal and regional agencies such as USDA and Indiana Soybean Alliance, respectively. She has presented her research at several top-tier universities, regional and national conferences. She has served as peer-reviewer for 20 international journals and ad-hoc reviewer for 4 national and international funding organizations including panel member for USDA.
                      • Peter Nagy, PhD
                        Professor, Department of Plant Pathology, University of Kentucky
                        Biography
                          PETER D. NAGY is a professor at the department of Plant Pathology, University of Kentucky, Lexington, USA. He is an expert on molecular biology of plant viruses; virus replication and recombination, biochemistry and cell biology of plant viruses. Based on systems biology approaches and using yeast and viruses, his laboratory is involved in dissecting the roles of host factors in plant virus infections. His work has been supported by grants from National Science Foundation, National Institute of Health and Kentucky Science Foundation. The main research projects are: 1. Development of the Tomato bushy stunt virus (TBSV)-yeast system to study virus replication and virus-host interactions. His lab has developed the TBSV-yeast system because of the advantages of using yeast as a model host. 2. Genome-wide screens and global proteomics approaches to identify host factors affecting TBSV replication. His lab have performed a dozen complementary genome-wide and global proteomics approaches that have led to the identification of ~500 host genes affecting TBSV replication in yeast. 3. Characterization of co-opted host factors critical for TBSV replication. 4. Discovery of cell-intrinsic restriction factors against TBSV replication. Dr. Nagy published 150 scientific papers and got numerous awards for his scientific work, including Science and Engineering Award from the Governor of Kentucky (2002), Faculty Futures Award, University of Kentucky (2004), Bobby Pass Excellence in Grantsmanship Award (2006 and 2013), Thomas P. Cooper Research Award (2007), University Research Professor Award (2007), Ruth Allen Research Award, Phytopathology Society (2008), and prestigious paper award, University of Kentucky (2016).
                        • Josh Quick
                          Research Fellow, University of Birmingham
                          Biography
                            Josh is a molecular biologist finishing up his PhD at the University of Birmingham. He is a member of Nick Loman's lab which explores the use of cutting-edge genomics and metagenomics approaches to the diagnosis, treatment and surveillance of infectious disease. In 2015 during the West-African Ebola virus outbreak he travelled to Guinea with a 'lab-in-a-suitcase' to establish a sequencing laboratory to perform genome sequencing of new cases in a matter of days. Last year, over the course of three trips to Brazil, he developed a multiplex version of the tiling-amplicon approach used previously leading to the first successful sequencing of Zika virus genomes directly from clinical samples. This was successfully used by the ZiBRA consortium and other groups investigating the origins of Zika virus in the Americas. Most recently, as part of a group of developers known as the Nanopore WGS consortium, he showed it was possible to sequence extremely long reads on the MinION using optimized extraction and rapid sequencing protocols. Generating runs with read N50's over 100 kilobases it demonstrated MinION is likely to be the platform of choice for those seeking highly contiguous assemblies for complex genomes.
                          • Winnie Ridderberg
                            Senior Scientist, Microbial Genomics, QIAGEN
                            Biography
                              Winnie Ridderberg, a microbiologist, received her doctoral degree from Aarhus University, Denmark. Winnie has almost a decade's experience in clinical microbiology, from working at the Department of Clinical Microbiology at Aarhus University Hospital. Winnie's primary research interest has been the microbiology of cystic fibrosis with specific focus on bacterial evolution and microbiome studies. Winnie joined QIAGEN Bioinformatics in early 2017 as a research scientist at the Microbial Genomics team.
                            • James Snyder, PhD
                              Professor of Pathology and Laboratory Medicine, University of Louisville
                              Biography
                                Dr. Snyder is the Medical Director of the Clinical Microbiology & Molecular Diagnostics Laboratory at the University of Louisville Hospital, and Professor of Pathology and Laboratory Medicine in the Department of Pathology and Laboratory Medicine at the University of Louisville, School of Medicine. He has been a part of ASM for many years. He currently serves on the Editorial Board for the Journal of Clinical Microbiology, is a member of the APHL Biosafety/Biosecurity Committee, and a past member of the APHL Sentinel Laboratory Partners Outreach Committee. He is also currently a member of the South Central Association for Clinical Microbiology Audioconference Planning Committee and President Elect of SCACM. He has authored or co-authored over 60 publications and was the recipient of the TREK Diagnostic ABMM/ABMLI Professional Recognition Award at ASM in 2009.
                              • Jennifer Spinler, PhD
                                Instructor, Pathology & Immunology, Baylor College of Medicine
                                Biography
                                  Dr. Spinler is an experienced classical microbiologist with extensive training in bacterial genetics and genomics currently serving as faculty at Baylor College of Medicine in the Texas Children's Microbiome Center. Her expertise in developing mutagenesis systems for investigations of gram-positive bacteria which has contributed to recent successes with genetics of probiotics; particularly in the area of antimicrobial production by Lactobacillus reuteri. Current research efforts combine comparative and functional genomics strategies with animal models and microbiome research to understand how individual probiotic organisms beneficially impact the larger microbiome community of the gastrointestinal tract and how these interactions protect against antibiotic-associated disease. Specifically, her research is aimed at developing adjunct probiotic therapies targeting C. difficile infection. As a probiotic researcher in a hospital-based microbiome center, Dr. Spinler has the benefit of combining her expertise with clinically relevant microbiome studies which has tremendous potential to impact our basic understanding of mechanisms of bacterial resistance and create new translational opportunities combatting antimicrobial resistance.
                                • Nobuhiro Suzuki, PhD
                                  Professor, Institute of Plant Science and Resources, Okayama University
                                  Biography
                                    Nobuhiro SUZUKI serves as a full professor of the Institute of Plant Stress and Resources, formerly Research Institute for Bioresouces at Okayama University and Editors for the plant and fungal virus section of Virus Research, Frontiers in Virology and the Journal of General Plant Pathology. He has been Guest Editors to PLoS Pathogens, PNAS, and mBio, and Board Members of Virology and Journal of Virology. Currently he is working on virus/host interactions using several different pathosystems involving fungal and plant viruses. Prior to coming to Kurashiki, Okayama Prefecture, he was a visiting fellow of the Center for Agricultural Biotechnology at the University of Maryland Biotechnology Institute for four years (1997-2001) to study molecular biology of hypoviruses in the laboratory of Professor Donald L. Nuss. Before visiting UMBI, he served as an assistant professor and a lecturer of the Biotechnology Institute at the Akita Prefectural College of Agriculture for 11 years (1988-1998) where he conducted a project on molecular characterization of rice dwarf phytoreovirus, a member of the family Reoviridae. He received awards from the Japanese Phytopathological Society of Japan and Japanese Society for Virology for his outstanding achievements in plant virology. Dr Suzuki received his M. S. (1985) in phytopathology and Ph. D (1989) in virology from Tohoku University in Sendai, Japan.
                                  • John Thomas, PhD
                                    Professor Emeritus, West Virginia University School of Medicine
                                    Biography
                                      Professor Emeritus John G. Thomas, PhD, is recognized as an "International Educator and Global Microbiologist " (www.globalbugs.com) having lectured in more than 43 countries while a clinical microbiologist in pathology (Professor), dentistry (Clinical Professor) and Graduate School Education (Adjunct Professor) for 54 years , his research emphasizing biofilms and medical devices. He has recently focused upon micro 3-D- bio Printing of contour fitting gauzes using bio-plastics and unique Prebiotics with Therapeutic Bacteria (Beneficial Bacteria) for chronic wound intervention (SMarT Gauze); this integrates a common pathway, visualized through his 'Microbial Clock' and recently created Center of Hologenomic Clinical Studies (www.globalbugs.com/Hologenomic Center) which underscores a "Dual Citizenship" and co evolution of symbiotic microbes and human ecosystems. "Microbes Matter". His Probiotic Solutions integrates Computer Decision Support for Probiotic (Beneficial Bacteria) Guidelines combining AI, Artificial Intelligence and Precision Medicine, expanded recently to emphasize Chronic Wound Care and Aging, hypothesized now as a disease. He has over 50 publications, multiple book chapters and significant grant support. His military obligation (1969-71)(wounds) and his sabbatical at Cardiff University, Wales, UK (2007)(oral health, biofilms) have remained a driving catalyst. He has been a member of the American Dental Association Scientific Advisory Committee for the last 8 years and American Society of Microbiology for 54 years. As Faculty at 3 national (Northeastern Ohio Universities College of Medicine, Rutgers University and West Virginia University) and 2 international Universities ( National University of Singapore and Cardiff University) during his career , he has received multiple Alumni and University awards for research and Student Mentoring ; retiring from West Virginia University in 2013 after 23 years as Professor Emeritus , he presently is expanding his research/teaching utilizing the advanced resources of the Allegheny Health Network (Center of Excellence in Biofilm Research) and Carnegie -Mellon University, Pittsburg, PA, and Mass. Gen. Hospital (Dept. of Anesthesia and Critical Care) with Harvard University, Boston, MA, all under the umbrella of his Global Microbiology Consulting. (GMC) (www.globalbugs.com)
                                    • Glenn Tillotson, PhD, FIDSA, FCCP
                                      Consultant Medical Microbiologist
                                      Biography
                                        Glenn Tillotson has 30+ years pharmaceutical experience in early pre-clinical and clinical research, commercialization, medical affairs, scientific communications including publication planning strategic drug development, life cycle management and global launch programs. Dr Tillotson has been instrumental in the development and launch of ciprofloxacin, moxifloxacin, gemifloxacin, fidaxomicin and most recently solithromycin. Glenn has held several key committee positions at the American College of Chest Physicians, he is on the Scientific Steering Committee for the GTCBio the Annual Summit on Anti-infective Partnering. Currently Dr Tillotson has published >150 peer-reviewed manuscripts, presented >270 scientific posters and is on several journal Editorial Advisory Boards including the Lancet Infectious Disease, eBioMedicine Expert Reviews in Anti-Infective Therapy and F1000.
                                      SEP 13 - 14 2017
                                      Microbiology & Immunology 2017
                                      17 142 15074

                                      The  LabRoots Microbiology & Immunology 2017 Virtual Conference is now On Demand! Join us in bringing the Microbiology research community together online in discovering new concepts, tools and techniques to apply to ongoing research and diagnostics. This conference is free to attend.

                                      Microbiology and Immunology cover an immense scope, encompassing various industries and research areas including pharmaceuticals, medicine, agriculture, and space. The development of new techniques and the ability to sequence organisms without the need to grow them in the laboratory has opened up a new world of microbial diversity and complexity we know little about. Being able to explore this biodiversity and use new knowledge for drug discovery and biotechnology applications is an exciting and expanding area of research.

                                      With progress made toward learning more about the world of microbiology and disease, the need for more rapid diagnosis, increased standardization of testing and greater adaptability to manage threats from newly evolved infectious microorganisms will become more and more apparent. The combination of the new tools being developed along with advancements in basic knowledge can lead to profound changes and growth in Microbiology and Immunology.

                                      Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.
                                       

                                      Topics for this years virtual conference included:

                                      • Virology and Bacteriology  
                                      • Antimicrobial
                                      • Food Microbiology
                                      • Beneficial Microbes
                                      • Immune Biomarkers: The Promises of Gene Sequencing and Personalized Medicine


                                      Continuing Education

                                      By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (PACE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.

                                       Use #LRmicro to follow the conversation!


                                      Speakers:
                                      • Henry Ford II Professor and Departmental Chair of Ecology and Evolutionary Biology, Microbiology Faculty, Yale School of Medicine
                                      • Professor of Biochemistry, John Coniglio Chair in Biochemistry, Vanderbilt University School of Medicine
                                      • Vice President of Precision Oncology, Vela Dx
                                      • Associate Professor, Laboratory Medicine and Medicine / Infectious Diseases Director, UCSF-Abbott Viral Diagnostics and Discovery Center Associate Director, UCSF Clinical Microbiology Laborat
                                      • Postdoctoral Research Scholar , Washington University School of Medicine
                                      • Professor, Applied Ecology, NC State University
                                      • Science Communications Manager, Innovative Genomics Institute
                                      • Director, Commercial Marketing, Accelerate Diagnostics
                                      • Associate Professor, Molecular Microbiology and Immunology, Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health
                                      • Associate Professor, Department of Biology, Purdue University
                                      • Professor, Department of Plant Pathology, University of Kentucky
                                      • Research Fellow, University of Birmingham
                                      • Senior Scientist, Microbial Genomics, QIAGEN
                                      • Professor of Pathology and Laboratory Medicine, University of Louisville
                                      • Instructor, Pathology & Immunology, Baylor College of Medicine
                                      • Professor, Institute of Plant Science and Resources, Okayama University
                                      • Professor Emeritus, West Virginia University School of Medicine
                                      • Consultant Medical Microbiologist

                                      Show Resources
                                      Agenda
                                      All times are Pacific Time
                                      • SEP 13, 2017 06:00 AM PDT
                                        Microbe Wars: The Rise of CRISPR Immunity and Technology
                                        Speaker: Megan Hochstrasser, PhD
                                      • SEP 13, 2017 06:00 AM PDT
                                        Next-generation probiotics targeting C. difficile infection
                                        Speaker: Jennifer Spinler, PhD
                                      • SEP 13, 2017 07:30 AM PDT
                                        Keynote Presentation: Using phage to select for evolution of reduced virulence in pathogenic bacteria
                                        Speaker: Paul Turner, PhD
                                      • SEP 13, 2017 09:00 AM PDT
                                        How Biomarker Testing Shapes Immunotherapy
                                        Speaker: Condie Carmack, PhD
                                        Sponsored By: Vela Diagnostics
                                      • SEP 13, 2017 09:00 AM PDT
                                        Insights into virus replication: the role of co-opted host proteins and lipids
                                        Speaker: Peter Nagy, PhD
                                      • SEP 13, 2017 10:30 AM PDT
                                        The Science of Farm to Table: Sourdough Bread as a Microcosm of the Global Food Crisis
                                        Speaker: Rob Dunn, PhD
                                      • SEP 13, 2017 12:00 PM PDT
                                        High Resolution Outbreak Tracing and Resistance Detection using Whole Genome Sequencing in the case of a Mycobacterium tuberculosis Outbreak
                                        Speaker: Winnie Ridderberg
                                      • SEP 13, 2017 01:30 PM PDT
                                        Integration of the Simplexa C. difficile Direct assay in a two-step algorithm for the laboratory diagnosis of C. difficile
                                        Speaker: James Snyder, PhD
                                        Sponsored By: DiaSorin
                                      • SEP 13, 2017 01:30 PM PDT
                                        The escalating challenges of antimicrobial resistance and the efforts to conquer these threats
                                        Speaker: Glenn Tillotson, PhD, FIDSA, FCCP
                                      • SEP 14, 2017 06:00 AM PDT
                                        A neo-virus lifestyle exhibited by a (+)ssRNA virus hosted in an unrelated dsRNA virus: taxonomic and evolutionary considerations
                                        Speaker: Nobuhiro Suzuki, PhD
                                      • SEP 14, 2017 06:00 AM PDT
                                        BENEFICIAL MICROBES: Sharing of the Microbial Informational Library
                                        Speaker: John Thomas, PhD
                                      • SEP 14, 2017 07:30 AM PDT
                                        Keynote Presentation: A Mechanistic Approach to Overcoming Antibacterial Drug Resistance
                                        Speaker: Neil Osheroff, PhD
                                      • SEP 14, 2017 09:00 AM PDT
                                        Development of tools enabling tunable, in situ delivery of therapeutics using probiotics
                                        Speaker: Nathan Crook, PhD
                                      • SEP 14, 2017 10:30 AM PDT
                                        Clinical and Laboratory Studies of Zika Virus Infection
                                        Speaker: Charles Chiu, MD, PhD
                                      • SEP 14, 2017 10:30 AM PDT
                                        Sex as a Biological Variable in Microbial Pathogenesis
                                        Speaker: Sabra Klein, PhD
                                      • SEP 14, 2017 12:00 PM PDT
                                        How to deploy a portable lab for the surveillance of emerging infectious diseases
                                        Speaker: Josh Quick
                                      • SEP 14, 2017 01:30 PM PDT
                                        Clinical and Economic Benefits of Faster Phenotypic Antimicrobial Susceptibility Testing
                                        Speaker: Levi Kirwin
                                        Sponsored By: Accelerate Diagnostics
                                      • SEP 14, 2017 01:30 PM PDT
                                        Dissecting the ecological and molecular mechanisms underlying the interaction between plant viruses and their insect vectors
                                        Speaker: Punya Nachappa, PhD
                                      • Virology and Bacteriology
                                      • SEP 13, 2017 06:00 AM PDT
                                        Microbe Wars: The Rise of CRISPR Immunity and Technology
                                        Speaker: Megan Hochstrasser, PhD
                                      • SEP 13, 2017 07:30 AM PDT
                                        Keynote Presentation: Using phage to select for evolution of reduced virulence in pathogenic bacteria
                                        Speaker: Paul Turner, PhD
                                      • SEP 13, 2017 09:00 AM PDT
                                        Insights into virus replication: the role of co-opted host proteins and lipids
                                        Speaker: Peter Nagy, PhD
                                      • SEP 13, 2017 01:30 PM PDT
                                        Integration of the Simplexa C. difficile Direct assay in a two-step algorithm for the laboratory diagnosis of C. difficile
                                        Speaker: James Snyder, PhD
                                        Sponsored By: DiaSorin
                                      • SEP 14, 2017 06:00 AM PDT
                                        A neo-virus lifestyle exhibited by a (+)ssRNA virus hosted in an unrelated dsRNA virus: taxonomic and evolutionary considerations
                                        Speaker: Nobuhiro Suzuki, PhD
                                      • SEP 14, 2017 10:30 AM PDT
                                        Clinical and Laboratory Studies of Zika Virus Infection
                                        Speaker: Charles Chiu, MD, PhD
                                      • SEP 14, 2017 12:00 PM PDT
                                        How to deploy a portable lab for the surveillance of emerging infectious diseases
                                        Speaker: Josh Quick
                                      • SEP 14, 2017 01:30 PM PDT
                                        Dissecting the ecological and molecular mechanisms underlying the interaction between plant viruses and their insect vectors
                                        Speaker: Punya Nachappa, PhD
                                      • Beneficial Microbes
                                      • SEP 13, 2017 06:00 AM PDT
                                        Next-generation probiotics targeting C. difficile infection
                                        Speaker: Jennifer Spinler, PhD
                                      • SEP 14, 2017 06:00 AM PDT
                                        BENEFICIAL MICROBES: Sharing of the Microbial Informational Library
                                        Speaker: John Thomas, PhD
                                      • SEP 14, 2017 09:00 AM PDT
                                        Development of tools enabling tunable, in situ delivery of therapeutics using probiotics
                                        Speaker: Nathan Crook, PhD
                                      • Immune Biomarkers: The Promises of Gene Sequencing and Personalized Medicine
                                      • SEP 13, 2017 09:00 AM PDT
                                        How Biomarker Testing Shapes Immunotherapy
                                        Speaker: Condie Carmack, PhD
                                        Sponsored By: Vela Diagnostics
                                      • SEP 13, 2017 12:00 PM PDT
                                        High Resolution Outbreak Tracing and Resistance Detection using Whole Genome Sequencing in the case of a Mycobacterium tuberculosis Outbreak
                                        Speaker: Winnie Ridderberg
                                      • Food Microbiology
                                      • SEP 13, 2017 10:30 AM PDT
                                        The Science of Farm to Table: Sourdough Bread as a Microcosm of the Global Food Crisis
                                        Speaker: Rob Dunn, PhD
                                      • Antimicrobial
                                      • SEP 13, 2017 01:30 PM PDT
                                        The escalating challenges of antimicrobial resistance and the efforts to conquer these threats
                                        Speaker: Glenn Tillotson, PhD, FIDSA, FCCP
                                      • SEP 14, 2017 07:30 AM PDT
                                        Keynote Presentation: A Mechanistic Approach to Overcoming Antibacterial Drug Resistance
                                        Speaker: Neil Osheroff, PhD
                                      • SEP 14, 2017 10:30 AM PDT
                                        Sex as a Biological Variable in Microbial Pathogenesis
                                        Speaker: Sabra Klein, PhD
                                      • SEP 14, 2017 01:30 PM PDT
                                        Clinical and Economic Benefits of Faster Phenotypic Antimicrobial Susceptibility Testing
                                        Speaker: Levi Kirwin
                                        Sponsored By: Accelerate Diagnostics
                                      Posters

                                      POSTER SUBMISSION GUIDELINES

                                      Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer reviewed. Submission is free.

                                      SUBMIT YOUR ABSTRACT

                                      Enter the following information to this Submission Form:

                                      • Poster Title
                                      • Your Name
                                      • Your Institution
                                      • Your Email
                                      • Abstract describing the poster

                                      All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

                                      If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

                                      Questions? Email Posters@LabRoots.com

                                      LabRoots Policy

                                      Sponsored By

                                      For information on becoming a sponsor or exhibitor, please click here.


                                      Continuing Education (CME/CE/CEU) Credits

                                      The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here

                                      The presentational method for this activity will be Lecture with an opportunity for real-time question and answer periods for the live activity, and on demand access of the presentation for the enduring material activity. Both the internet live course and the internet activity enduring material is geared towards Primary Care Clinicians, All Health Care Professionals, Academia, and Industry. This activity will encompass the following desirable physician attributes:  Patient Care & Procedural Skills, Medical Knowledge, Professionalism, and Practice-Based Learning & Improvement.

                                      Desired Outcomes

                                      At the end of the activity, participants should be able to:

                                      1. Demonstrate an understanding of the concept of the microbiome and its importance in human health
                                      2. Identify routes of transmission of the microbiome to a human host
                                      3. Integrate the provided content into practice in ways that are consistent with acknowledged practice guidelines and that improve patient management and outcomes
                                      4. Utilize technologies currently available for use in the clinic and the limitations of these technologies
                                      5. Cite current and established medical science principles and the application of these principles to patient care
                                      6. Perform continuous self-assessment and learning to improve one’s professional and clinical practices, including how to interpret results in ways most useful to the patient

                                      This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME®) through the joint providership of CME Consultants and LabRoots. CME Consultants is accredited by the ACCME® to provide continuing medical education for physicians.

                                      CME Consultants designates each activity for the number of AMA PRA Category 1 CreditsTM listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

                                      (Internet) Live Activity, 6.0 AMA PRA Category 1 CreditsTM

                                      (Internet Activity) Enduring Material, 6.0 AMA PRA Category 1 CreditsTM

                                      --

                                      Enduring Material Release date: 9/15/17

                                      Enduring Material Termination date: 3/15/18

                                       

                                      In accordance with the Americans with Disability Act (ADA), please contact LabRoots at ce@labroots.com should you require special assistance.

                                       


                                      Committee

                                      To download the Program Committee brochure here.


                                      • Committee Chair: Tony Rook, MS

                                        Tony A. Rook leads the Microbiology Resource Center at The Sherwin-Williams Company in Cleveland, OH, USA, where he has built a world-class Microbiology Center of Excellence to focus on global preservation strategies, continuous improvement of industrial hygiene practices, and ...

                                        See more See less
                                      • Emily Hollister, PhD

                                        Dr. Hollister is a microbial ecologist and bioinformaticist. She is interested in quantifying and characterizing microbial communities from a wide variety of environments, including the human body. Utilizing high throughput, next-generation DNA and RNA sequence approaches, her ...

                                        See more See less
                                      • Marilyn Roossinck, PhD

                                        Dr. Roossinck received a PhD in 1986 from the University of Colorado School of Medicine in Microbiology and Immunology, studying Hepatitis B virus, on an National Institutes of Health fellowship. Following a postdoctoral fellowship at Cornell University, where she began studying ...

                                        See more See less
                                      • Glenn Tillotson, SVP

                                        Glenn is a Senior Vice President at Cempra Inc in Chapel Hill, USA. He is trained in medical microbiology and infectious diseases and almost 30 of pharmaceutical industry experience in various areas including clinical research, commercialization, scientific communications ...

                                        See more See less
                                      • Radhakrishna Tirumalai, PhD

                                        Radhakrishna Tirumalai, PhD US Pharmacopeial Convention Dr. Tirumalai has been at the USP since 2003 and is currently a Principal Scientific Liaison in the Global Science and Standards Division. He is the Staff Liaison to the USP Expert Committees on Microbiology, and Toxicology ...

                                        See more See less
                                      • Ivan Brukner, PhD

                                        Dr Ivan Brukner entered into genomic era back in 1989 (ex-Yugoslavia), trying to describe and solve repeating sequence "branching motif problem" in building whole genome sequence. Next 5-10 years, his research was targeting sequence-dependent DNA structural problems, where ...

                                        See more See less
                                      • Philip Geis

                                        Philip A. Geis is a native Texan who earned bachelor and doctor of philosophy degrees in microbiology and mycology from The University of Texas. Between these efforts, he served in the US Army with final duty as clinical microbiologist for the Army's 45th field hospital APO ...

                                        See more See less
                                      Help

                                      General LabRoots Questions

                                      For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                      Contact us

                                      Virtual Events and Webinars

                                      Supported Configurations

                                      • Operating System Internet Explorer Firefox Chrome Safari
                                        Vista IE8+ FF10+ Chrome15+
                                        Windows 7 IE8+ FF10+ Chrome15+
                                        Windows 8 IE10 FF10+ Chrome15+
                                        Mac OS X   FF10+ Chrome15+ Safari5.1+
                                      • Cookie settings: session cookies enabled
                                      • Browser configuration must have JavaScript enabled
                                      • Adobe Flash player 10.2 or later

                                      To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                      Internet Connection

                                      • A minimum of 100Kbps is recommended for audio-only events
                                      • A minimum of 300Kbps is recommended for speaker on-video events

                                      Computer Equipment

                                      • Screen Resolution: Minimum 1024x768
                                      • Video Card: 65,000 colors minimum
                                      • Sound card and speakers (or headphones) for hearing webcast in full format
                                      • Audio Card: 16-bit minimum
                                      • RAM: 512MB of free RAM

                                      Firewall Protocol

                                      • HTTP on port 80 or HTTPS on port 443
                                      • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                      • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                      Work-At-Home Attendees

                                      • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                      For A Seamless Experience

                                      When using a mobile device, FREE Mobile Apps are available:

                                      - For viewing Webinars:

                                      - For viewing Virtual Events

                                      Attendee Guide

                                      • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                      Virtual Event and Webinar Support:

                                      Continuing Education (CME/CE) Support

                                      Loading Comments...
                                      Show Resources